CYCC Stock Predictions
| Recent CYCC Stock Price | CYCC Stock Predictions | |
| $2.30 |  +595.65% |
$16.00 |
| Recent CYCC Analyst Ratings Breakdown, Making CYCC Stock Predictions | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 2 | 2 | 2 | 2 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 1 | 1 | 1 | 1 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.67 | 1.67 | 1.67 | 1.67 |
For the CYCC stock predictions from the analysts covering Cyclacel Pharmaceuticals Inc, we have collected all of the individual CYCC stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 2 different analysts covering CYCC (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since CYCC stock predictions may vary widely, another useful metric to consider is the median CYCC stock prediction, which represents the price at which half of the analysts
made CYCC stock predictions that were higher and half made CYCC stock predictions that were lower. This makes for a different take on the CYCC stock predictions out there, as compared to average or mean.
And that median across all the individual CYCC stock predictions was: $16.0 as of 2024-04-25.
The very highest of the CYCC stock predictions for one year price target was $21.0, while the very lowest of the CYCC stock predictions in the analyst group was
$11.0 (with a standard deviation of $7.071). Get the latest Zacks research report on CYCC — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
• BMY Stock Predictions
• HBIO Stock Predictions
• NRZ Stock Predictions
• RDNT Stock Predictions
• XENT Stock Predictions
• CE Stock Predictions
• BECN Stock Predictions
• ENSG Stock Predictions
• AYX Stock Predictions
|
|||||||||
|
|
|
|
|
|
Free CYCC Email Alerts:
Avg. Broker Rec.
 
|
Buy (3.33 out of 4) 52nd percentile
(ranked higher than approx. 52% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
